Skip to main content
Premium Trial:

Request an Annual Quote

Lucence Dx, Stanford University Applying AI to Liver Cancer Diagnosis, Treatment

NEW YORK (360Dx) – Lucence Diagnostics said today that it is teaming with Stanford University School of Medicine to develop artificial intelligence algorithms for improving diagnosis and treatment of liver cancer by analyzing both imaging and molecular data.

In conjunction with Stanford biomedical informatician Olivier Gevaert, Singapore-based Lucence will process a dataset of more than 5,000 patients with liver cancer to look for changes and patterns in imaging and mutations that could predict the effectiveness of a therapy. The partners will rely on Lucence's LiquidHallMark, a blood test that analyzes the DNA of cancer-related mutations and viral targets.

"By combining radiology with our proprietary sequencing technology and track record in liver cancer data modeling, our AI algorithms will assist physicians in making better treatment decisions," Lucence Diagnostics Founder and CEO Min-Han Tan said in a statement.

The Scan

Genetic Ancestry of South America's Indigenous Mapuche Traced

Researchers in Current Biology analyzed genome-wide data from more than five dozen Mapuche individuals to better understand their genetic history.

Study Finds Variants Linked to Diverticular Disease, Presents Polygenic Score

A new study in Cell Genomics reports on more than 150 genetic variants associated with risk of diverticular disease.

Mild, Severe Psoriasis Marked by Different Molecular Features, Spatial Transcriptomic Analysis Finds

A spatial transcriptomics paper in Science Immunology finds differences in cell and signaling pathway activity between mild and severe psoriasis.

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.